Yabao Pharmaceutical Group Co Ltd (600351) — Net Asset Momentum
Yabao Pharmaceutical Group Co Ltd (600351) recorded a net asset momentum of -3.3% as of December 2024, with net assets of CN¥2.89 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Yabao Pharmaceutical Group Co Ltd to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Yabao Pharmaceutical Group Co Ltd Net Asset Momentum (1999–2024)
This chart tracks Yabao Pharmaceutical Group Co Ltd's year-over-year net asset growth across 26 annual reporting periods from 1999 to 2024. The most recent momentum reading is -3.3%, with net assets of CN¥2.89 Billion CNY as of December 2024. Read Yabao Pharmaceutical Group Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Yabao Pharmaceutical Group Co Ltd (1999–2024)
The table below shows the complete annual net asset history for Yabao Pharmaceutical Group Co Ltd from 1999 to 2024, covering 26 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 600351 company net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥2.89 Billion | CN¥3.54 Billion | CN¥649.02 Million | ▼ -3.3% |
| 2023 | CN¥2.99 Billion | CN¥3.85 Billion | CN¥860.33 Million | ▼ -0.4% |
| 2022 | CN¥3.01 Billion | CN¥4.13 Billion | CN¥1.12 Billion | ▲ +1.5% |
| 2021 | CN¥2.96 Billion | CN¥4.08 Billion | CN¥1.11 Billion | ▲ +5.2% |
| 2020 | CN¥2.82 Billion | CN¥4.01 Billion | CN¥1.20 Billion | ▲ +3.4% |
| 2019 | CN¥2.72 Billion | CN¥4.31 Billion | CN¥1.59 Billion | ▼ -9.6% |
| 2018 | CN¥3.01 Billion | CN¥4.83 Billion | CN¥1.81 Billion | ▲ +3.4% |
| 2017 | CN¥2.91 Billion | CN¥4.37 Billion | CN¥1.45 Billion | ▲ +6.7% |
| 2016 | CN¥2.73 Billion | CN¥4.21 Billion | CN¥1.48 Billion | ▲ +2.0% |
| 2015 | CN¥2.68 Billion | CN¥4.25 Billion | CN¥1.57 Billion | ▲ +47.2% |
| 2014 | CN¥1.82 Billion | CN¥3.18 Billion | CN¥1.37 Billion | ▲ +7.3% |
| 2013 | CN¥1.70 Billion | CN¥3.20 Billion | CN¥1.51 Billion | ▲ +5.0% |
| 2012 | CN¥1.62 Billion | CN¥2.88 Billion | CN¥1.27 Billion | ▲ +39.4% |
| 2011 | CN¥1.16 Billion | CN¥2.27 Billion | CN¥1.11 Billion | ▲ +15.6% |
| 2010 | CN¥1.00 Billion | CN¥2.43 Billion | CN¥1.43 Billion | ▲ +11.5% |
| 2009 | CN¥899.55 Million | CN¥2.21 Billion | CN¥1.31 Billion | ▲ +8.3% |
| 2008 | CN¥830.32 Million | CN¥1.67 Billion | CN¥843.93 Million | ▲ +118.5% |
| 2007 | CN¥380.08 Million | CN¥1.07 Billion | CN¥694.23 Million | ▲ +13.6% |
| 2006 | CN¥334.54 Million | CN¥1.01 Billion | CN¥675.74 Million | ▼ -5.6% |
| 2005 | CN¥354.37 Million | CN¥1.13 Billion | CN¥780.42 Million | ▲ +4.8% |
| 2004 | CN¥338.16 Million | CN¥937.81 Million | CN¥599.65 Million | ▲ +6.3% |
| 2003 | CN¥318.26 Million | CN¥664.93 Million | CN¥346.67 Million | ▲ +14.6% |
| 2002 | CN¥277.81 Million | CN¥447.38 Million | CN¥169.57 Million | ▲ +202.5% |
| 2001 | CN¥91.84 Million | CN¥261.43 Million | CN¥169.58 Million | ▲ +7.2% |
| 2000 | CN¥85.64 Million | CN¥221.07 Million | CN¥135.42 Million | ▲ +10.3% |
| 1999 | CN¥77.61 Million | CN¥193.41 Million | CN¥115.80 Million | — |